biospecimen__admin__batch_number	384.50.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	624A8DC3-59C1-429C-BCAE-DDDDB75526E1
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AA3A-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AA3A-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AA3A-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104898
biospecimen__bio__day_of_creation	17
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	02
biospecimen__bio__pathology_report_file_name	TCGA-DD-AA3A.F1055545-91C4-4397-BD34-FE995A3E9B05.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A37G
biospecimen__bio__plate_row	H
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AA3A
biospecimen__shared__patient_id	AA3A
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	5ABBCF83-C0B4-49EA-B43C-A2B19941DCF8
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.9
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	1
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.1
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	81
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	256
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocholangiocarcinoma (Mixed)
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G4
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	4bbcbb17-ac87-4b06-ada1-77cc549b658e
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AA3A-01A-11R-A37G-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	2738b982-8700-4919-9640-ab4b477fd8dd
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	1f153ceb-5531-4093-befe-148abced41e6
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	56abd1c1-8f22-4856-8b0a-73d7e092bdb3
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:31:12.037302-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	9daa0404-a37e-5a8e-97c1-63bbb37d229e
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1928
gdc__demographic__year_of_death	2010
gdc__diagnoses__age_at_diagnosis	29712
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-29712.0
gdc__diagnoses__days_to_death	410.0
gdc__diagnoses__diagnosis_id	4b7a94fb-0563-59b3-a696-7acd83006ddf
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8180/3
gdc__diagnoses__primary_diagnosis	Combined hepatocellular carcinoma and cholangiocarcinoma
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	26.314635323012148
gdc__exposures__exposure_id	6d6f943d-4ead-5280-88e9-1d6b5fa2c2e0
gdc__exposures__height	151.0
gdc__exposures__weight	60.0
gdc__file_id	9cbc0b98-2394-45e3-a5a5-c83d9c9c16c8
gdc__file_name	271f459e-7601-4223-9f2e-2633b7434566.mirbase21.mirnas.quantification.txt
gdc__file_size	50324
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	86f3968471055d60c13dcc32e9156ebd
gdc__portions__is_ffpe	false
gdc__portions__portion_id	89880f5a-b725-422f-9293-90fc0759ae50
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1559
gdc__samples__initial_weight	100.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	F1055545-91C4-4397-BD34-FE995A3E9B05
gdc__samples__sample_id	3a71a328-228a-4609-b162-f38c825503b7
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	5.0
gdc__slides__percent_tumor_cells	95.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	6ad3b88d-bc24-4c85-b497-889e56cb2116
gdc__submitter_id	mirna_swap_dr11_115_MirnaExpression9b027b62-f216-4f46-b0bd-7ad86f109563_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	e34f8022-1500-5485-ad29-9ff9667bc910
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:19.976+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4bbcbb17-ac87-4b06-ada1-77cc549b658e-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4bbcbb17-ac87-4b06-ada1-77cc549b658e-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129695
manually_curated__local_md5	eb66117aa1fbfe6090ef58b9e1c2ee12
manually_curated__opengdc_download_date	2018-10-16T17:10:24.000287+02:00
manually_curated__opengdc_file_md5	8f4da0768d42ded35f50149a368b8635
manually_curated__opengdc_file_size	50323
manually_curated__opengdc_id	4bbcbb17-ac87-4b06-ada1-77cc549b658e-meq
manually_curated__origin_file_size	129695
manually_curated__origin_last_modified_date	Tue Oct 16 17:53:00 CEST 2018
manually_curated__origin_md5	eb66117aa1fbfe6090ef58b9e1c2ee12
manually_curated__tissue_status	tumoral
